Skip to main content
Premium Trial:

Request an Annual Quote

IDBS to Acquire InforSense

NEW YORK (GenomeWeb News) - ID Business Solutions has inked an agreement to acquire InforSense for an undisclosed sum, IDBS announced today.

The all-cash deal is expected to be completed in July.

IDBS said that the addition of InforSense's product portfolio will expand the firm's large-scale data integration efforts and broaden its life sciences portfolio into the growth areas of biomarker development and personalized medicine. Guildford, UK-based IDBS said that InforSense has developed "state of the art applications to integrate genomics, biomarker and clinical data, that provide a unique offering to researchers in the developing areas of translational and personalised medicine."

"This is a major enabling step towards becoming the number one informatics partner of R&D worldwide," Neil Kipling, CEO and founder of IDBS, said in a statement. "An additional facet of this acquisition is the opportunity to cement a strategic informatics research relationship with Imperial College. The combination of our rigorous software development and powerful new research capabilities creates a groundbreaking new organisation."

Following the deal, InforSense Founder Yi Ke Guo will become chief innovation officer at IDBS.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.